AASLD expects more than 9500 hepatologists and hepatology health professionals from all over the world to exchange the latest liver disease research, discuss treatment outcomes and networking with colleagues.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Showing posts with label AASLD 2015 Meeting/abstract. Show all posts
Showing posts with label AASLD 2015 Meeting/abstract. Show all posts
Tuesday, October 20, 2015
AASLD 2015: Late-breaking abstracts [PDF] are now available for download.
Sunday, October 4, 2015
AASLD - The Liver Meeting® 2015 abstract supplement available online
AASLD expects more than 9500 hepatologists and hepatology health professionals from all over the world to exchange the latest liver disease research, discuss treatment outcomes and networking with colleagues.
The Liver Meeting® 2015 abstract supplement, in full text, is available as a PDF, and online in a special issue of Hepatology.
Late-breaking Abstracts
Meeting Event Link

Late-breaking Abstracts
Late-breaking abstracts will be available on October 20th at 10 am ET
Subscribe to:
Posts (Atom)